IFCC Feed2021-07-28T00:05:26Z Insoft Feed Generator /ifcc-news/ On demand content for IFCC Live Webinar on 20th July: "Newborn Screening" is available2021-07-22T13:50:05Z /ifcc-news/2021-07-22-the-on-demand-content-is-available/ IFCC Office

Recorded webinar in English available on demand here

Recorded webinar in Spanish available on demand here

The goal of Newborn Screening is the pre-symptomatic detection of infants with congenital conditions so that treatment may be commenced as early as possible to prevent or improve, the long-term consequences of the condition. In this webinar the speakers discussed the different situation of the newborn screening programs in different countries.

The Webinar consisted of three talks (20 minutes each) and was followed by the panel discussion

Talk 1: Situation of Latin America in Neonatal Screening. Panorama in Uruguay
Speaker: Dr. Cecilia Queijo

Talk 2: Panorama of Neonatal Screening in Brazil
Speaker: Dr. Armando A. Fonseca

Talk 3: Panorama of Neonatal Screening in Spain as a model for programs with different degrees of development
Speaker: Dr. José Angel Cocho de Juan

Chair: Dr. Ana Lena, IFCC EB COLABIOCLI

 

Certificate of Participation: available for all registrants

The IFCC Live Webinar Series is partially sponsored by Siemens Healthineers and Boston Children's Hospital

 

 

    

]]>
On demand content for IFCC Live Webinar on 15th July: Point of Care Testing in Resource Limited Settings: Dotting the “i's” and crossing the “t’s” is available2021-07-19T13:13:36Z /ifcc-news/2021-07-10-on-demand-content-for-poct-webinar-is-available/ IFCC Office

The on demand content for the 15th July 2021

IFCC Free webinar 

Point of care testing in resource limited settings:
dotting the "i's" and crossing the "t's"

 is available! 

Click here to watch it

 

 

 Point-of-Care Testing is ideally suited to resource limited settings: it can bring testing to the patient in the field as well as enable reliable laboratory testing in an environment lacking the complicated hospital infrastructure. However, it is vulnerable to the same problems that plague all laboratory tests. The presenters discussed the particular challenges they faced and some of the resolutions they developed.

 

Certificate of Participation: available for all registrants

 

The IFCC Live Webinar Series is partially sponsored by Siemens Healthineers and Boston Children's Hospital

 

 

    

]]>
IFCC eNews No 7/8 July-August 20212021-07-19T12:06:11Z /ifcc-news/2021-07-09-ifcc-enews-no-78-jul-aug-2021/ IFCC Office  

 


IFCC eNews: July/August 2021

eNews logo large globe
Full PDF version

IN THIS ISSUE:

  • EDITORIAL
    • Message from the eNews Editor
  • THE VOICE OF IFCC 
    • IFCC President's message – July-August 2021
    • Dogs sniff out COVID-19 infections
    • Register to the IFCC Live Webinar - 15th July 2021: Point of Care Testing in Resource Limited Settings: Dotting the “i’s” and crossing the “t’s
  •  IFCC: THE PEOPLE
    • IFCC call for nominations
    • Welcome and thanks to the Chairs
  • CONTRIBUTE TO THE IFCC eNEWS
    • CLSI and IFCC partnership promotes global harmonization of clinical laboratory practices 
    • Democratization of education: adaptive learning courses in laboratory medicine are now available without a subscription fee!
    • Clinical leader in Croatia calls upon integrated clinical care teams for healthcare excellence 
    • Laboratory-led company-wide screening programs for safe back to work strategies during COVID-19 pandemic 
    • Improving patient experiences via reliable pre-surgical biomarker risk assessments in patients undergoing eye surgery 
    • Improving care and overall experience for patients who present to a Tanzania clinic with suspected cardiovascular diseases 
    • Increased detection of acute myocardial infarction in women using sex-specific upper reference limits
  • NEWS FROM REGIONAL FEDERATIONS AND MEMBER SOCIETIES
    • News from the Spanish Society of Laboratory Medicine (SEQCML)
    • News from the Pakistan Society of Chemical Pathologists 
    • EFLM Task Force on European Regulatory Affairs (TF-ERA)
  • IFCC WELCOMES A NEW FULL MEMBER
    • Libyan Association of Clinical Pathology (LACP)
  • IFCC'S CALENDAR OF CONGRESSES, CONFERENCES & EVENTS
    • Calendar of IFCC Congresses/Conferences and Regional Federations' Congresses
    • Corporate Member Events with IFCC auspices
    • Other events with IFCC auspices
]]>
On demand content of the IFCC Live Webinar: Quality in Clinical Laboratory is available2021-07-19T12:13:07Z /ifcc-news/2021-06-17-ifcc-live-webinar-on-quality-in-clinical-laboratory-on-demand-content-is-available-now/ IFCC Office

IFCC webinar "Quality in Clinical Laboratories"

on demand content is available at:

https://www.workcast.com/ControlUsher.aspx?cpak=3762578129337370&pak=3894650988959297

It is widely recognized that errors in laboratory medicine could significantly compromise patient safety independently of time, place and measurement procedure. All clinical laboratories have to implement measures to detect high-risk processes, and to identify incidents and associated risks to patient safety. A wide number of instruments have been implemented to maintain the so-called “quality” of the process in clinical laboratories, and recently the IFCC have created a new task force on Global Lab Quality with the aim of providing scientific support teams to train and develop training programs for participating laboratories.

 

The IFCC Live Webinar Series is partially sponsored by Siemens and Boston Children's Hospital

 

 

    

]]>
IFCC Handbook 2021 - 20232021-07-19T12:13:07Z /ifcc-news/2021-07-01-ifcc-handbook-2021-2023/ IFCC Office IFCC Handbook 2021 - 2023

The Handbook puts in one place all the information about the function and operation of the IFCC. This includes the organisation of the FCC and its aims and strategic objectives over the three-year life of the Executive Board. Also, it includes details of IFCC programmes and projects. The Handbook lists, in logical order, IFCC Regional Organisations, Divisions, Committees and Working Groups. The Full Members, Corporate Members and Affiliate Members are also included. Contact names and addresses are included for the many people who work with and for the IFCC. Finally, the necessary Statutes and Rules of the IFCC are published in the Handbook. We thank the many individuals responsible for preparing this useful document. In particular we thank Dr Graham Beastall, an IFCC Past President, whose long experience and deep knowledge of IFCC was fundamental for the revision and completion of this publication.

 

Khosrow Adeli                                                                         David Kinniburgh

President                                                                                 Secretary

 

Click on the image to download your copy!

]]>
DIAGNÓSTICO in VITRO June issue: new format & improved readability!2021-07-19T12:13:07Z /ifcc-news/2021-06-30-div-june-2021/ IFCC Office Auspiciado por la Federación Internacional de Química Clínica, "Diagnóstico in Vitro" es un nexo de unión entre los países Latinoamericanos, Portugal y España, que contribuye a difundir temas científicos a través de Internet, facilitando el conocimiento de publicaciones y temas de interés comunes a las ciencias del laboratorio clínico.

Número Junio 2021

Cover PDF.jpg Cover Flip.jpg

Click here to access the PDF version
Clic aquí para acceder la versión PDF

Click here to access the Flip version
Clic aquí para acceder la versión Flip

EDITORIAL
NOVEDADES Y NOTICIAS
ARTÍCULOS CIENTÍFICOS ORIGINALES
ARTÍCULOS CIENTÍFICOS
REPORTAJE
]]>
eJIFCC Vol 32 n° 22021-07-19T12:13:07Z /ifcc-news/2021-06-28-ejifcc-vol-32-n-2/ IFCC Office  

eJIFCC Volume 32 no 2 - 2021

In this issue: POCT – making the point
 
eJIFCC New 2015 Thumb for web.jpg
Click here to download a PDF of the full issue.
 
1 Introducing the eJIFCC special issue on “POCT – making the point"
Guest editor: Sergio Bernardini
2 Controlling reliability, interoperability and security of mobile health solutions
Damien Gruson
3 Best laboratory practices regarding POCT in different settings (hospital and outside the hospital)
Adil I. Khan
4 POCT accreditation ISO 15189 and ISO 22870: making the point
Paloma Oliver, Pilar Fernandez-Calle, Antonio Buno
5 Utilizing point-of-care testing to optimize patient care
James H. Nichols
6 POCT: an inherently ideal tool in pediatric laboratory medicine
Siobhan Wilson, Mary Kathryn Bohn, Khosrow Adeli
7 Point of care testing of serum electrolytes and lactate in sick children
Aashima Dabas, Shipra Agrawal, Vernika Tyagi, Shikha Sharma, Vandana Rastogi, Urmila Jhamb, Pradeep Kumar Dabla
8 Training and competency strategies for point-of-care testing
Sedef Yenice
9 Leading POCT networks: operating POCT programs across multiple sites involving vast geographical areas and rural communities
Edward W. Randell, Vinita Thakur
10 Connectivity strategies in managing a POCT service
Rajiv Erasmus, Sumedha Sahni, Rania El-Sharkawy
11 POCT in developing countries
Prasenjit Mitra, Praveen Sharma
12 How could POCT be a useful tool for migrant and refugee health?
Sergio Bernardini, Massimo Pieri, Marco Ciotti
13 Direct to consumer laboratory testing (DTCT) – opportunities and concerns
Matthias Orth
14 Clinical assessment of the DiaSorin LIAISON SARS-CoV-2 Ag chemiluminescence immunoassay
Gian Luca Salvagno, Gianluca Gianfilippi, Giacomo Fiorio, Laura Pighi, Simone De Nitto, Brandon M. Henry, Giuseppe Lippi
15 Lessons learned from the COVID-19 pandemic: emphasizing the emerging role and perspectives from artificial intelligence, mobile health, and digital laboratory medicine
Pradeep Kumar Dabla, Damien Gruson, Bernard Gouget, Sergio Bernardini, Evgenija Homsak
16 Catering for the point-of-care testing explosion
Adil I. Khan, Mazeeya Khan, Rosy Tirimacco
17 Predictive model of severity in SARS CoV-2 patients at hospital admission using blood-related parameters
Laura Criado Gómez, Santiago Villanueva Curto, Maria Belén Pérez Sebastian, Begoña Fernández Jiménez, Melisa Duque Duniol
18 Clinicians’ Probability Calculator to convert pre-test to post-test probability of SARS-CoV-2 infection based on method validation from each laboratory
Zoe Brooks, Saswati Das, Tom Pliura
19 Prevalence of aminotransferase macroenzymes in rheumatoid arthritis patients and impact on their management
Maja Šimac, Daniel Victor Šimac, Lidija Bilić-Zulle
20 Malignant hyperthermia syndrome: a clinical case report
Isabel Sánchez-Molina Acosta, Guillermo Velasco de Cos, Matilde Toval Fernández

 

]]>
IFCC Information Guide on COVID-19 - 29 June 2021 Updates2021-07-19T12:13:07Z /ifcc-news/2021-06-29-ifcc-information-guide-on-covid-19/ IFCC Office  

 

 

IFCC Information Guide on COVID-19

Click aquí para descargar el Resumen traducido de la Guía de Información de la IFCC sobre COVID-19
Kliknutím zde stáhnete českou verzi IFCC informačního  souhrnu o COVID 19 z 16 . dubna 2020

 

 

 

 

Coronavirus disease 2019, abbreviated to COVID-19, is an emerging global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As the number of individuals infected with COVID-19 continues to rise globally and healthcare systems become increasingly stressed, it is clear that the clinical laboratory will play an essential role in this crisis, contributing to patient screening, diagnosis, monitoring/treatment, as well as epidemiologic recovery/surveillance. This guide aims to organize relevant available information on laboratory screening, testing protocols, diagnosis, and other general information on COVID-19 for laboratory professionals, including links to helpful resources and interim guidelines. It will be continually updated as new guidelines and literature become available.

 

Click here to access to the different chapters of the IFCC Guide 

 


 

 

Table of Contents:

  1. General Information
  2. Patient Screening
  3. Diagnostic Testing
  4. Biosafety Guidelines for the Clinical Laboratory
  5. Biochemical Monitoring of COVID-19 Patients
  6. Other Educational Materials & Webinars
  7. Big Data Tools
  8. Vaccination: Considerations for the Clinical Laboratory

_____________________________________________________________________

]]>
Call for Nominations2021-07-19T12:13:07Z /ifcc-news/2021-06-22-ifcc-call-for-nominations/ IFCC Office  

 

=================

New IFCC Task Forces

  • Outcome Studies in Laboratory Medicine (TF-OSLM)
    5 Members: 1 who will serve as Chair and 4  Members. Time in office July 2021 - December 2023.
    Deadline to receive nominations and supporting documents: June 30th, 2021.

 

  • Global Reference Interval Database (TF-GRID)
    5 Members: 1 who will serve as Chair and 4  Members. Time in office July 2021 - December 2023.
    Deadline to receive nominations and supporting documents: June 30th, 2021.

=================

Education and Management Division

  • Committee on Kidney Disease (C-KD): one member position - time in office 2021-2023.
    Deadline to receive nominations and supporting documents: August 20th 

 

 

=================

Applications for these positions should be submitted by IFCC members (National Societies or Corporate members). If you are interested, please refer to your National Representative or Corporate Representative for information on procedures for nominations. Find your representative HERE

For further information on the open Calls for Nominations, please visit the IFCC Call for Nominations page.

=================

]]>
Scam messages2021-07-19T12:13:07Z /ifcc-news/2021-06-21-scam-messages/ IFCC Office The email messages (and websites) look official enough that they deceive many people into believing that they are legitimate. Believing that these emails are legitimate, unsuspecting people often respond to the email's requests for their credit card numbers, passwords, account information, or other personal information.

Never respond to requests for personal information via email. Legitimate organizations will never ask for passwords, credit card numbers, or other personal information in an email.  If you receive an email requesting this kind of information, DO NOT RESPOND, DO NOT REPLY, DO NOT CLICK ON LINKS OR IMAGES, and DO NOT OPEN ANY ATTACHMENTS with the message.  If you think the email is legitimate, contact the company through their official contacts to confirm. Updating your systems with good security software can help defend data, users, systems, and companies from a wide range of risks.

Remember that the IFCC never requests money or credit card numbers, passwords, account information, or other personal information.

]]>